<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04250311909554</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>9G-Visc 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04653</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:23.266Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909547</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>9G-Visc 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04651</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:22.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909530</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>9G-Visc 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04650</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:21.496Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909523</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>9G-Visc 1.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04649</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:20.564Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909516</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>9G-Gel 2.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04648</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:19.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909509</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>9G-Gel 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04647</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:18.763Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909493</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>HiMed 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04580</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:17.879Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909486</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>HiMed 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00169</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:16.966Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909479</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>HiMed 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00166</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:16.065Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909455</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>ViscoMed 2.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00245</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:15.162Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909448</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>ViscoMed 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00242</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:14.268Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909349</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>an-bfh 2.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03360</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:13.372Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909332</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>an-bfh 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03359</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:12.462Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909301</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>an-viscose 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03357</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:11.567Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909226</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>i-Visc 2.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04526</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:10.663Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909219</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>i-Visc 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04525</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:09.768Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909202</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04527</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:08.872Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909196</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04524</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:07.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909172</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04522</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:00.945Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909165</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04521</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:00.093Z</lastUpdated>
  </row>
</eudamedExport>